Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05829226
Status:
RECRUITING
Last Update Posted:
2024-01-11
First Post:
2023-03-30
Brief Title:
A Phase 1 Study With LYT-200 in Patients With RelapsedRefractory Acute Myeloid Leukemia AML or With RelapsedRefractory High-risk Myelodysplastic Syndrome MDS
Sponsor:
PureTech
Organization:
PureTech
Organization Data
Organization:
PureTech
Class:
INDUSTRY
Study ID:
LYT-200-2022-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PureTech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None